Cite
HARVARD Citation
Croze, L. et al. (n.d.). Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor‐specific antibodies. Transplant international. pp. 775-783. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Croze, L. et al. (n.d.). Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor‐specific antibodies. Transplant international. pp. 775-783. [Online].